• 1-800-526-8630U.S. (TOLL FREE)
  • 1-917-300-0470EAST COAST U.S.
  • +353-1-416-8900REST OF WORLD

PRODUCT FILTERS

REGION

7,418
3,681
3,566
2,958
2,890

COUNTRY

2,472
909
285
272
236

CATEGORIES

  • 933
  • 179
    • 43
    • 264
    • 51
  • 182
  • 829
    • 51
  • 508
  • 227
  • 242
  • 60
  • 65
  • 875
  • 1,525
  • 742
  • 20
  • 501
  • 1,434
  • 2,413
    • 85
    • 124
    • 66
    • 65
    • 37
    • 37
    • 12
    • 12
    • 11
    • 18
  • 23
  • 270
  • 32
  • 2,699
SHOW ALL…

PRICE

2,822
8,236
17,355
30,591

PUBLISHED

2,222
3,944
12,800
30,591

PRODUCT TYPE

27,614
1,094
1,034
524
163
58
23
21
19
16
6
3
1

Pharmaceuticals

(30,591 Products)

The pharmaceutical industry has been for decades one of the most profitable worldwide. Serious challenges, such as the expiry of long-term lucrative patents (Lipitor, to mention just one) and the cuts in healthcare and R&D in many countries worldwide, can pose a challenge to the growth of the industry. Which drug can save the life of the pharmaceutical industry? Highly differentiated strategies: this is what companies should focus on now if they want to stay competitive. Do you want to know more?

You can get a detailed picture of the market and refine your marketing, brand, and sales strategies with the reliable, up-to-date business information provided by the extensive range of reports, books and subscriptions listed under Research and Markets’ Pharmaceuticals category. They cover markets, companies (big Pharma, mid-sized specialty pharmaceutical companies, generic manufacturers, and small firms), technologies, e-healthcare, pharmaeconomics, drug discovery, and drug delivery.

The product coverage is huge. It includes OTC drugs as well disorder and goal-specific products related to respiration, oncology, vitamins, cardio, analgesics, central nervous system, generics, immune disorders, and women’s health. Show Less
Read more

PRODUCT TITLE
Phosphoinositide 3-Kinase Beta (PI3K Beta) Inhibitors -Pipeline Insights Phosphoinositide 3-Kinase Beta (PI3K Beta) Inhibitors -Pipeline Insights - Product Thumbnail Image

Phosphoinositide 3-Kinase Beta (PI3K Beta) Inhibitors -Pipeline Insights

“Phosphoinositide 3-Kinase Beta (PI3K Beta) Inhibitors-Pipeline Insights, 2014” provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report...

February 2015
FROM
Peripheral Decarboxylase Inhibitors -Pipeline Insights Peripheral Decarboxylase Inhibitors -Pipeline Insights - Product Thumbnail Image

Peripheral Decarboxylase Inhibitors -Pipeline Insights

“Peripheral Decarboxylase Inhibitors-Pipeline Insights, 2014” provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish...

February 2015
FROM
Methionine Aminopeptidase 2 (Metap2) Inhibitors -Pipeline Insights Methionine Aminopeptidase 2 (Metap2) Inhibitors -Pipeline Insights - Product Thumbnail Image

Methionine Aminopeptidase 2 (Metap2) Inhibitors -Pipeline Insights

“Methionine Aminopeptidase 2 (Metap2) Inhibitors-Pipeline Insights, 2014” provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is...

February 2015
FROM
G Protein-Coupled Receptor 119 (GPR119) Agonists -Pipeline Insights G Protein-Coupled Receptor 119 (GPR119) Agonists -Pipeline Insights - Product Thumbnail Image

G Protein-Coupled Receptor 119 (GPR119) Agonists -Pipeline Insights

“G Protein-Coupled Receptor 119 (GPR119) Agonists-Pipeline Insights, 2014” provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report...

February 2015
FROM
Fusion Inhibitors -Pipeline Insights Fusion Inhibitors -Pipeline Insights - Product Thumbnail Image

Fusion Inhibitors -Pipeline Insights

“Fusion Inhibitors-Pipeline Insights, 2014” provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding...

February 2015
FROM
Folic Acid Antagonists -Pipeline Insights Folic Acid Antagonists -Pipeline Insights - Product Thumbnail Image

Folic Acid Antagonists -Pipeline Insights

“Folic Acid Antagonists-Pipeline Insights, 2014” provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding...

February 2015
FROM
D3 Agonists -Pipeline Insights D3 Agonists -Pipeline Insights - Product Thumbnail Image

D3 Agonists -Pipeline Insights

“D3 Agonists-Pipeline Insights, 2014” provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding for...

February 2015
FROM
D1 Antagonists -Pipeline Insights D1 Antagonists -Pipeline Insights - Product Thumbnail Image

D1 Antagonists -Pipeline Insights

“D1 Antagonists-Pipeline Insights, 2014” provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding...

February 2015
FROM
5-HT4 Partial Agonists -Pipeline Insights 5-HT4 Partial Agonists -Pipeline Insights - Product Thumbnail Image

5-HT4 Partial Agonists -Pipeline Insights

“5-HT4 Partial Agonists-Pipeline Insights, 2014” provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding...

February 2015
FROM
5-HT2C Antagonists -Pipeline Insights 5-HT2C Antagonists -Pipeline Insights - Product Thumbnail Image

5-HT2C Antagonists -Pipeline Insights

“5-HT2C Antagonists-Pipeline Insights, 2014” provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish the understanding...

February 2015
FROM
Protein Kinase C (PKC) Inhibitors -Pipeline Insights Protein Kinase C (PKC) Inhibitors -Pipeline Insights - Product Thumbnail Image

Protein Kinase C (PKC) Inhibitors -Pipeline Insights

“Protein Kinase C (PKC) Inhibitors-Pipeline Insights, 2014” provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish...

February 2015
FROM
Prostaglandin F2-Alpha Receptor Agonists -Pipeline Insights Prostaglandin F2-Alpha Receptor Agonists -Pipeline Insights - Product Thumbnail Image

Prostaglandin F2-Alpha Receptor Agonists -Pipeline Insights

“Prostaglandin F2-Alpha Receptor Agonists-Pipeline Insights, 2014” provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish...

February 2015
FROM
Hypoxia Inducible Factor Prolyl-4-Hydroxylase (HIF-PH) Inhibitors -Pipeline Insights Hypoxia Inducible Factor Prolyl-4-Hydroxylase (HIF-PH) Inhibitors -Pipeline Insights - Product Thumbnail Image

Hypoxia Inducible Factor Prolyl-4-Hydroxylase (HIF-PH) Inhibitors -Pipeline Insights

“Hypoxia Inducible Factor Prolyl-4-Hydroxylase (HIF-PH) Inhibitors-Pipeline Insights, 2014” provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective...

February 2015
FROM
Fatty Acid Synthase (FAS) Inhibitors -Pipeline Insights Fatty Acid Synthase (FAS) Inhibitors -Pipeline Insights - Product Thumbnail Image

Fatty Acid Synthase (FAS) Inhibitors -Pipeline Insights

“Fatty Acid Synthase (FAS) Inhibitors-Pipeline Insights, 2014” provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish...

February 2015
FROM
Cannabinoid Receptor Type 2 (CB2) Agonists -Pipeline Insights Cannabinoid Receptor Type 2 (CB2) Agonists -Pipeline Insights - Product Thumbnail Image

Cannabinoid Receptor Type 2 (CB2) Agonists -Pipeline Insights

“Cannabinoid Receptor Type 2 (CB2) Agonists-Pipeline Insights, 2014” provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to...

February 2015
FROM
Cannabinoid Receptor Type 1 (CB1) Agonists -Pipeline Insights Cannabinoid Receptor Type 1 (CB1) Agonists -Pipeline Insights - Product Thumbnail Image

Cannabinoid Receptor Type 1 (CB1) Agonists -Pipeline Insights

“Cannabinoid Receptor Type 1 (CB1) Agonists-Pipeline Insights, 2014” provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to...

February 2015
FROM
Vascular Endothelial Growth Factor C (VEGF-C) Inhibitors -Pipeline Insights Vascular Endothelial Growth Factor C (VEGF-C) Inhibitors -Pipeline Insights - Product Thumbnail Image

Vascular Endothelial Growth Factor C (VEGF-C) Inhibitors -Pipeline Insights

“Vascular Endothelial Growth Factor C (VEGF-C) Inhibitors-Pipeline Insights, 2014” provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the...

February 2015
FROM
Vascular Endothelial Growth Factor A (VEGF-A) Activator -Pipeline Insights Vascular Endothelial Growth Factor A (VEGF-A) Activator -Pipeline Insights - Product Thumbnail Image

Vascular Endothelial Growth Factor A (VEGF-A) Activator -Pipeline Insights

“Vascular Endothelial Growth Factor A (VEGF-A) Activator-Pipeline Insights, 2014” provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the...

February 2015
FROM
Tumor Necrosis Factor Receptor (TNFR) Antagonists -Pipeline Insights Tumor Necrosis Factor Receptor (TNFR) Antagonists -Pipeline Insights - Product Thumbnail Image

Tumor Necrosis Factor Receptor (TNFR) Antagonists -Pipeline Insights

“Tumor Necrosis Factor Receptor (TNFR) Antagonists-Pipeline Insights, 2014” provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report...

February 2015
FROM
Tumor Necrosis Factor (TNF) Inhibitors -Pipeline Insights Tumor Necrosis Factor (TNF) Inhibitors -Pipeline Insights - Product Thumbnail Image

Tumor Necrosis Factor (TNF) Inhibitors -Pipeline Insights

“Tumor Necrosis Factor (TNF) Inhibitors-Pipeline Insights, 2014” provides comprehensive insights about pipeline drugs across this mechanism of action (MOA). A key objective of the report is to establish...

February 2015
FROM
Loading Indicator

Our Clients

Pfizer, Inc. Grünenthal GmbH GlaxoSmithKline PLC Abbott Laboratories Ltd. Roche Diagnostics Ltd. Novo Nordisk A/S